Sanofi SA vs Vital Farms Inc — how do they compare? Sanofi SA trades at $44.05 (market cap $104.83B), while Vital Farms Inc trades at $13.16 (market cap $590.45M). The key difference: Sanofi SA is far larger — about 177.5× Vital Farms Inc's market cap, and Sanofi SA pays a 5.5% dividend while Vital Farms Inc pays none. Which is the better fit depends on your goals.
| SNY | VITL | |
|---|---|---|
Market Cap | $104.83B | $590.45M |
Sector | Health | Consumer Staples |
52-Week High | $52.34 | $52.41 |
52-Week Low | $41.33 | $8.28 |
Enterprise Value | $121.32B | $593.26M |
Dividend Yield | 5.5% | — |
Trailing returns across standard periods
Latest headlines on both assets
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Read more on SNY →Vital Farms is a leading provider of ethically produced, pasture-raised eggs and butter in the United States. Operating as a Public Benefit Corporation, it manages a network of over 650 family farms to deliver high-welfare food products. It leverages a scalable 'asset-light' partnership model that prioritizes transparency and animal welfare to meet the growing consumer demand for clean-label and sustainable food sources.
Read more on VITL →